1
|
Ma XX, Xie HY, Hou PP, Wang XJ, Zhou W, Wang ZH. Nuclear Factor Erythroid 2-Related Factor 2 is Essential for Low- Normobaric Oxygen Treatment-Mediated Blood-Brain Barrier Protection Following Ischemic Stroke. Mol Neurobiol 2024; 61:2938-2948. [PMID: 37950788 DOI: 10.1007/s12035-023-03767-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Accepted: 11/01/2023] [Indexed: 11/13/2023]
Abstract
Cerebral ischemia/reperfusion (I/R) injury increases blood-brain barrier (BBB) permeability, leading to hemorrhagic transformation and brain edema. Normobaric oxygen (NBO) is a routine clinical treatment strategy for this condition. However, its neuroprotective effects remain controversial. This study investigated the effect of different NBO concentrations on I/R injury and explores the involvement of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway in the underlying mechanism. A mouse middle cerebral artery occlusion (MCAO) model, and an oxygen and glucose deprivation (OGD) model featuring mouse brain microvascular endothelial cells (ECs) called bEnd.3, were used to investigate the effect of NBO on I/R injury. A reactive oxygen species (ROS) inducer and Nrf2-knockdown by RNA were used to explore whether the Nrf2 pathway mediates the effect of NBO on cerebrovascular ECs. In the early stage of MCAO, 40% O2 NBO exposure significantly improved blood perfusion in the ischemic area and effectively relieved BBB permeability, cerebral edema, cerebral injury, and neurological function after MCAO. In the OGD model, 40% O2 NBO exposure significantly reduced apoptosis, inhibited ROS generation, reduced ER stress, upregulated the expression of tight junction proteins, and stabilized the permeability of ECs. Blocking the Nrf2 pathway nullified the protective effect of 40% O2 NBO on ECs after OGD. Finally, our study confirmed that low concentrations of NBO have a neuroprotective effect on I/R by activating the Nrf2 pathway in ECs.
Collapse
Affiliation(s)
- Xiao-Xiao Ma
- Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Hai-Yi Xie
- Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Pin-Pin Hou
- Central Laboratory, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - Xiao-Jing Wang
- Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Wei Zhou
- Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
| | - Zhen-Hong Wang
- Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
| |
Collapse
|
2
|
Kelestemur T, Beker MC, Caglayan AB, Caglayan B, Altunay S, Kutlu S, Kilic E. Normobaric oxygen treatment improves neuronal survival functional recovery and axonal plasticity after newborn hypoxia-ischemia. Behav Brain Res 2019; 379:112338. [PMID: 31733311 DOI: 10.1016/j.bbr.2019.112338] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2019] [Revised: 10/16/2019] [Accepted: 10/30/2019] [Indexed: 02/07/2023]
Abstract
BACKGROUND Newborn hypoxia ischemia (HI) is one of the most prevalent cases in the emergency and can result from fetal hypoxia during delivery. In HI, restricted blood supply to the fetal brain may cause epilepsy or mental disorders. METHODS In the present study, seven-day-old pups were subjected HI and treated with different normobaric oxygen (NBO) concentrations (21%, 70% or 100%). In the acute phase, we analyzed infarct area, disseminate neuronal injury and surviving neurons. In addition, we studied the regulation of PTEN and MMP-9 proteins which were suggested to be activated by HI in the ischemic tissue. Moreover, long-term effects of NBO treatments were evaluated with open field, rotarod and Barnes maze tests. We also examined axonal plasticity with EGFP-AAV injection. RESULTS Here, we demonstrate that hyperoxic NBO concentration causes an increase in cellular survival and a decrease in the number of apoptotic cells, meanwhile inhibiting the proteins involved in cellular death mechanisms. Moreover, we found that hyperoxia decreases anxiety, promotes motor coordination and improve spatial learning and memory. Notably that axonal sprouting was promoted by hyperoxia. CONCLUSION Our data suggest that NBO is a promising approach for the treatment of newborn HI, which encourage proof-of-concept studies in newborn.
Collapse
Affiliation(s)
- Taha Kelestemur
- School of Medicine, Department of Physiology, Istanbul Medipol University, 34810, Istanbul, Turkey; Regenerative and Restorative Medical Research Center (REMER), Istanbul Medipol University, 34810, Istanbul, Turkey
| | - Mustafa C Beker
- School of Medicine, Department of Physiology, Istanbul Medipol University, 34810, Istanbul, Turkey; Regenerative and Restorative Medical Research Center (REMER), Istanbul Medipol University, 34810, Istanbul, Turkey
| | - Ahmet B Caglayan
- Regenerative and Restorative Medical Research Center (REMER), Istanbul Medipol University, 34810, Istanbul, Turkey; International School of Medicine, Department of Physiology, Istanbul Medipol University, 34810, Istanbul, Turkey
| | - Berrak Caglayan
- Regenerative and Restorative Medical Research Center (REMER), Istanbul Medipol University, 34810, Istanbul, Turkey; International School of Medicine, Department of Medical Biology, Istanbul Medipol University, 34810, Istanbul, Turkey
| | - Serdar Altunay
- School of Medicine, Department of Physiology, Istanbul Medipol University, 34810, Istanbul, Turkey; Regenerative and Restorative Medical Research Center (REMER), Istanbul Medipol University, 34810, Istanbul, Turkey
| | - Selim Kutlu
- School of Medicine, Department of Physiology, Necmettin Erbakan University, 42080, Konya, Turkey
| | - Ertugrul Kilic
- School of Medicine, Department of Physiology, Istanbul Medipol University, 34810, Istanbul, Turkey; Regenerative and Restorative Medical Research Center (REMER), Istanbul Medipol University, 34810, Istanbul, Turkey.
| |
Collapse
|